en

PRODUCT DETAIL

Mometasone Sandoz 50 mikrogramov

Code 3076A
MA number 69/0471/12-S
Product Form: aer nau 1x18 g/140 dávok (fľ.HDPE s rozpr.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: Sandoz Pharmaceuticals d.d., Slovenia
Therapeutic Class: 69 - OTORHINOLARYNGOLOGICA
ATC:
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AD Corticosteroids
R01AD09 Mometasone
Shelf life: 24
Container: bottle HDPE with nebuliser
Route of admin.: Nasal use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 24.10.2012
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Mometasone_Sandoz_05.2020.doc  
PIL: PIL_Mometasone_Sandoz 50 mcg_08_2022.pdf  
Safety feature Yes
Data update: 14.05.2020
eu-flag.png sk-flag.png